Exchange Traded Concepts LLC boosted its holdings in Cigna Group (NYSE:CI – Free Report) by 31.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,539 shares of the health services provider’s stock after buying an additional 2,055 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Cigna Group were worth $2,350,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in CI. Harbor Capital Advisors Inc. raised its stake in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares during the last quarter. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group in the fourth quarter worth $28,000. Collier Financial acquired a new stake in Cigna Group in the third quarter valued at $34,000. True Wealth Design LLC raised its position in Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock worth $43,000 after purchasing an additional 85 shares during the last quarter. Finally, Founders Capital Management raised its position in Cigna Group by 53.0% during the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after purchasing an additional 53 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.
Cigna Group Stock Up 3.3%
Shares of NYSE:CI opened at $266.54 on Wednesday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The business’s 50-day moving average is $276.72 and its 200-day moving average is $279.57. The company has a market capitalization of $70.24 billion, a price-to-earnings ratio of 12.02, a P/E/G ratio of 0.89 and a beta of 0.27.
Cigna Group Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were paid a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.
Analysts Set New Price Targets
A number of equities research analysts have commented on CI shares. Truist Financial upped their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft raised their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research report on Tuesday, February 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. UBS Group reissued a “buy” rating and set a $375.00 target price on shares of Cigna Group in a research report on Monday, February 9th. Finally, Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $307.00 to $358.00 in a report on Thursday, March 12th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $333.11.
Get Our Latest Research Report on CI
Insiders Place Their Bets
In related news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by insiders.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Read More
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
